Immunetics, Inc. Awarded Phase II SBIR Grant from NIAID
Cambridge, MA, September 1997 - Immunetics, Inc., manufacturer of infectious disease immunoassay kits, has been awarded a $700,000 Phase II SBIR Grant from National Institute of Allergies and Infectious Diseases (NIAID), a division of NIH, for development of a Rapid Confirmatory Lyme Disease Test. This fast and accurate point-of-care Lyme Disease test will expedite the diagnosis and treatment of Lyme patients. Intended for use by clinicians and healthcare practitioners, the rapid test will offer the same level of confirmatory accuracy as a Western Blot test without the complex procedure, lengthy processing time, and problems with interpretation. In addition, the rapid test will provide a cost-effective alternative to the current screening/confirmatory antibody testing being performed in clinical laboratories.